Publication | Closed Access

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients

ThrombopoiesisThrombosisBreast OncologyBlood PlateletBreast Cancer PatientsMedicineMalignant Blood DisorderImmunologyHematologyPretreatment Neutrophil/lymphocyte RatioLong-term MortalityBreast CancerOncologyRadiation OncologyCancer ResearchHealth Sciences